Researchers discover role of microglia during early progression of Alzheimer's disease

October 5, 2015, Boston University Medical Center
Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.

For the first time, researchers have determined how toxic tau fibrils spread by the help of brain immune cells called microglia during the early stages of Alzheimer's disease (AD). The discovery of this new pathway may lead to a therapeutic target for AD, one that has not been previously identified.

In patients with AD, the gradual decline in cognitive function and loss of neurons is preceded by the harmful build-up of the in the brain. Tau accumulates as called fibrils in that are critical for learning and memory. But how they spread during the early stage of AD was previously unknown.

"This study found that tau can be carried from one neuron to another by the brain's own in a process that may contribute to the progression of AD," explained corresponding author Tsuneya Ikezu, MD, PhD, professor of pharmacology & experimental therapeutics and neurology at Boston University School of Medicine.

The findings appear online in the journal Nature Neuroscience.

One important function of microglia is to constantly survey the brain environment for sensing and clearing damage and infection. For this purpose, microglia actively engulf dead cells, debris, inactive synapses or even unhealthy neurons. Then, to transfer signaling molecules and present antigen to activate an immune response, microglia release nano-scale particles called exosomes, which can be taken up by other cells.

The researchers hypothesize that in an early stage of AD brain, microglia may spread the harmful protein tau by taking up tau-containing fibrils and then releasing them via the exosomes, which can be absorbed by nearby neurons.

Using an experimental model, the researchers found that pharmacologic depletion of microglia suppressed the spread of tau from one brain region to another. The depletion of microglia also restored the neural excitation, which is affected by the spread of tau. They also found that pharmacologic inhibition of exosome production suppressed the tau spread in the brain.

"Our results using an experimental model of AD suggest that microglia could facilitate the spread of tau fibrils between neurons by releasing tau-containing exosomes. This finding indicates that molecules involved in exosome release by microglia has a great potential as novel therapeutic targets to prevent the progression of AD," added Ikezu.

Explore further: One step closer to defeating Alzheimer's disease

More information: Depletion of microglia and inhibition of exosome synthesis halt tau propagation, DOI: 10.1038/nn.4132

Related Stories

One step closer to defeating Alzheimer's disease

March 2, 2015
Tackling brain inflammation ameliorates Alzheimer's disease (AD), according to a study published in The Journal of Experimental Medicine.

Old drug offers new hope to treat Alzheimer's disease

September 21, 2015
Scientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau-related dysfunction in an animal model of frontotemporal dementia (FTD). Salsalate ...

Brain cell activity regulates Alzheimer's protein

February 26, 2014
Increased brain cell activity boosts brain fluid levels of a protein linked to Alzheimer's disease, according to new research from scientists at Washington University School of Medicine in St. Louis.

Immune cells of the brain renew hopes for curing Alzheimer's disease

November 30, 2012
A new experimental study carried out in mice shows that microglia, immune cells of the brain, might play a key role in protecting the brain from Alzheimer's disease (AD). It is long believed that toxic sticky protein deposits ...

How protein tangles accumulate in the brain and cause neurological disorders

September 2, 2015
A new Sanford Burnham Prebys Medical Discovery Institute (SBP) study takes a step forward in understanding how similar, yet genetically unrelated neurodegenerative diseases, such as Alzheimer's disease, frontal temporal dementia, ...

Recommended for you

A new way of thinking about tau kinetics, an essential component of Alzheimer's disease

March 21, 2018
Alzheimer's disease is most often characterized by two different pathologies in the brain: plaque deposits of a protein called beta-amyloid and tangles of another protein called tau. A paper appearing March 21 in the journal ...

Could drugs used after an organ transplant protect against Alzheimer's?

March 21, 2018
A UT Southwestern study in mice provides new clues about how a class of anti-rejection drugs used after organ transplants may also slow the progression of early-stage Alzheimer's disease.

Cell therapy could improve brain function for Alzheimer's disease

March 15, 2018
Like a great orchestra, your brain relies on the perfect coordination of many elements to function properly. And if one of those elements is out of sync, it affects the entire ensemble. In Alzheimer's disease, for instance, ...

Physically fit women nearly 90 percent less likely to develop dementia

March 14, 2018
Women with high physical fitness at middle age were nearly 90 percent less likely to develop dementia decades later, compared to women who were moderately fit, according to a study published the March 14, 2018, online issue ...

Poor sleep may heighten Alzheimer's risk

March 12, 2018
(HealthDay)—Older adults who are sleepy during the day might have harmful plaque building in their brain that is a sign of impending Alzheimer's disease, researchers report.

Dementia patients with distorted memories may actually retain key information – researchers say

March 7, 2018
Some memories containing inaccurate information can be beneficial to dementia sufferers because it enables them to retain key information researchers say.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.